Drug recall · February 5, 2020
Montelukast Sodium Chewable Tablets recall
Why: Failed Dissolution Specifications: testing revealed low out of specification result in one lot of product
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc. Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himachal Pradesh, India NDC 33342-111-10
- Lots / codes
Lot #: BMD8901B, Exp. Date 02/2021
- Quantity
- 10680 units
- Company
- Macleods Pharma Usa Inc, Plainsboro, NJ
- Distribution
- Nationwide within the United States
- Initiated
- January 20, 2020 · Voluntary: Firm initiated
- Classified
- January 31, 2020
- Reported
- February 5, 2020
- Ended
- April 26, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Montelukast
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.